$LTBR
LIGHTBRIDGE Corp Stock $ltbr

$ltbr Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000147793224006831 Filed on November 01, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$1.676M	$1.609M
YoY Change		4.17%	-20.49%
% of Gross Profit
Research & Development		$1.299M	$552.8K
YoY Change		134.93%	219.75%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$2.975M	$2.162M
YoY Change		37.6%	-1.59%
Operating Profit		-$2.975M	-$2.162M
YoY Change		37.6%	1.71%
Interest Expense		$318.7K	$322.1K
YoY Change		-1.06%	266.24%
% of Operating Profit
Other Income/Expense, Net		$318.6K	$322.1K
YoY Change		-1.06%	351.48%
Pretax Income		-$2.656M	-$1.840M
YoY Change		44.37%	-9.7%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings		-$2.656M	-$1.840M
YoY Change		44.37%	-9.7%
Net Earnings / Revenue
Basic Earnings Per Share			-$0.15
Diluted Earnings Per Share		-$0.19	-$0.15
COMMON SHARES
Basic Shares Outstanding	15.77M shares	14.60M shares	12.57M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.63M	$29.24M
YoY Change	-8.9%	-6.55%
Cash & Equivalents	$26.63M	$29.24M
Short-Term Investments
Other Short-Term Assets	$403.9K	$252.4K
YoY Change	60.03%	-17.49%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$27.04M	$29.49M
YoY Change	-8.31%	-6.65%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$472.9K	$486.4K
YoY Change	-2.78%
Total Long-Term Assets	$581.7K	$595.2K
YoY Change	-2.27%	452.39%
TOTAL ASSETS
Total Short-Term Assets	$27.04M	$29.49M
Total Long-Term Assets	$581.7K	$595.2K
Total Assets	$27.62M	$30.08M
YoY Change	-8.19%	-5.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$59.57K	$75.64K
YoY Change	-21.25%	-24.36%
Accrued Expenses	$1.100M	$800.0K
YoY Change	37.5%	-27.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.160M	$875.6K
YoY Change	32.43%	-26.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.160M	$875.6K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.160M	$875.6K
YoY Change	32.43%	-26.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$160.2M	-$150.0M
YoY Change	6.81%	5.22%
Common Stock	$15.28K	$12.93K
YoY Change	18.11%	12.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.46M	$29.21M
YoY Change
Total Liabilities & Shareholders Equity	$27.62M	$30.08M
YoY Change	-8.19%	-5.09%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$2.656M	-$1.840M
YoY Change	44.37%	-9.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.944M	-$1.135M
YoY Change	71.27%	9.58%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$640.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$640.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.512M	2.171M
YoY Change	-30.38%	-28.85%
NET CHANGE
Cash From Operating Activities	-1.944M	-1.135M
Cash From Investing Activities	0.000	-640.0
Cash From Financing Activities	1.512M	2.171M
Net Change In Cash	-432.1K	1.036M
YoY Change	-141.71%	-48.63%
FREE CASH FLOW
Cash From Operating Activities	-$1.944M	-$1.135M
Capital Expenditures	$0.00	$640.00
Free Cash Flow	-$1.944M	-$1.136M
YoY Change	71.17%	9.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	ltbr	Outstanding Restricted Stock Awards OutstandingRestrictedStockAwards	545992	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	527697	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13698274	shares
CY2023Q4	ltbr	Outstanding Restricted Stock Awards OutstandingRestrictedStockAwards	557688	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	510787	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	498177	shares
CY2023Q4	ltbr	Common Stock And All Common Stock Equivalents CommonStockAndAllCommonStockEquivalents	14209061	shares
	ltbr	Proceed From Sale Of Available For Sale Securities ProceedFromSaleOfAvailableForSaleSecurities	75000000.0	usd
CY2024Q3	ltbr	Proceeds From Sale Of Available For Sale Securities B8 ProceedsFromSaleOfAvailableForSaleSecuritiesB8	12600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	503843	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	545992	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	451404	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1093354	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	955247	shares
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	100000	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	100000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	400000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	800000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	0	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1200000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	500000	usd
	ltbr	Contractual Commitments ContractualCommitments	2400000	usd
CY2023	ltbr	Contractual Commitments ContractualCommitments	3600000	usd
	ltbr	Project Task Tatement Postemployment Obligations ProjectTaskTatementPostemploymentObligations	2400000	usd
	ltbr	Lessee Operating Lease Term LesseeOperatingLeaseTerm	P12M
	us-gaap	Operating Lease Payments OperatingLeasePayments	8000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	24000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	73000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	23000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	70000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001084554
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13698274	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	547362	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	503843	shares
CY2024Q3	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	545992	shares
CY2023Q3	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	451404	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1093354	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	955247	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-34487
	dei	Entity Registrant Name EntityRegistrantName	LIGHTBRIDGE CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1975651
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11710 Plaza America Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2000
	dei	Entity Address City Or Town EntityAddressCityOrTown	Reston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20190
	dei	City Area Code CityAreaCode	571
	dei	Local Phone Number LocalPhoneNumber	730-1200
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	LTBR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15766902	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26634951	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28598445	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	403922	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	207063	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	27038873	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28805508	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	472875	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	483000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108865	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	108865	usd
CY2024Q3	us-gaap	Assets Assets	27620613	usd
CY2023Q4	us-gaap	Assets Assets	29397373	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1159566	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	486326	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1159566	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	486326	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15276331	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13698274	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	15276	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	13698	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	186693926	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	181295125	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160248155	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152397776	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	26461047	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28911047	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27620613	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29397373	usd
CY2024Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	0	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1676209	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1609142	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5626567	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5071889	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1298601	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	552751	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3232036	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1367650	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2974810	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2161893	usd
	us-gaap	Operating Expenses OperatingExpenses	8858603	usd
	us-gaap	Operating Expenses OperatingExpenses	6439539	usd
CY2024Q3	ltbr	Contributed Services Research And Development Income ContributedServicesResearchAndDevelopmentIncome	0	usd
CY2023Q3	ltbr	Contributed Services Research And Development Income ContributedServicesResearchAndDevelopmentIncome	0	usd
	ltbr	Contributed Services Research And Development Income ContributedServicesResearchAndDevelopmentIncome	0	usd
	ltbr	Contributed Services Research And Development Income ContributedServicesResearchAndDevelopmentIncome	31028	usd
CY2024Q3	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
	us-gaap	Other Operating Income OtherOperatingIncome	0	usd
	us-gaap	Other Operating Income OtherOperatingIncome	31028	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2974810	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2161893	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8858603	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6408511	usd
CY2024Q3	us-gaap	Interest Income Other InterestIncomeOther	318649	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	322065	usd
	us-gaap	Interest Income Other InterestIncomeOther	1008224	usd
	us-gaap	Interest Income Other InterestIncomeOther	869879	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	318649	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	322065	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1008224	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	869879	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2656161	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1839828	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7850379	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5538632	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2656161	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1839828	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7850379	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5538632	usd
CY2024Q3	ltbr	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.19
CY2023Q3	ltbr	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.15
	ltbr	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.57
	ltbr	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.47
CY2024Q3	ltbr	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	14189787	shares
CY2023Q3	ltbr	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	12252342	shares
	ltbr	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	13871756	shares
	ltbr	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	11902010	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29118155	usd
CY2023Q1	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	731052	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	215000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	284360	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2026580	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28321987	usd
CY2023Q2	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	1583330	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	316798	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1672224	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28564891	usd
CY2023Q3	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	2167104	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	300729	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1839828	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	29207896	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28911047	usd
CY2024Q1	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	1221982	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	255000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	456904	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2819584	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	28025349	usd
CY2024Q2	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	982642	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2024Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-10583	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	384216	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2374634	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	27021990	usd
CY2024Q3	ltbr	Shares Issued Registered Offerings Net Of Offering Costs Amount SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount	1511741	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	195000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	388477	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2656161	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	26461047	usd
	us-gaap	Profit Loss ProfitLoss	7850379	usd
	us-gaap	Profit Loss ProfitLoss	5538632	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	50806	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1229597	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	901887	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	37665	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	137139	usd
	ltbr	Increase Decrease In Prepaid Project Costs And Other Long Term Assets IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets	-10125	usd
	ltbr	Increase Decrease In Prepaid Project Costs And Other Long Term Assets IncreaseDecreaseInPrepaidProjectCostsAndOtherLongTermAssets	141375	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	928240	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	740308	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5669276	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4144951	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	640	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-640	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3705782	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4481486	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3705782	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4481486	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1963494	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	335895	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28598445	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28899997	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26634951	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29235892	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	ltbr	Payment Of Accrued Liabilities With Common Stock PaymentOfAccruedLiabilitiesWithCommonStock	255000	usd
	ltbr	Payment Of Accrued Liabilities With Common Stock PaymentOfAccruedLiabilitiesWithCommonStock	215000	usd
	ltbr	Common Stock Issued For Consulting Services CommonStockIssuedForConsultingServices	180000	usd
	ltbr	Common Stock Issued For Consulting Services CommonStockIssuedForConsultingServices	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company will need additional funding and/or in-kind support via a combination of strategic alliances, government grants, further offerings of equity securities, or an offering of debt securities in order to support its future research and development (R&D) activities required to further enhance and complete the development and commercialization of its fuel products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There can be no assurance that the Company will be able to successfully continue to conduct its operations if there is a lack of financial resources available in the future to continue its fuel development activities, and a failure to do so would have a material adverse effect on the Company’s future R&D activities, financial position, results of operations, and cash flows. Also, the success of the Company’s operations will be subject to other numerous contingencies, some of which are beyond management’s control. These contingencies include general and regional economic conditions, contingent liabilities, potential competition with other nuclear fuel developers, including those entities developing accident tolerant fuels (ATFs), changes in government regulations, risks related to the R&D of our nuclear fuel, regulatory approval of the Company’s fuel, support for nuclear power, changes in accounting and taxation standards, inability to achieve overall short-term and long-term R&D milestones toward commercialization, future impairment charges to the Company’s assets, and global or regional catastrophic events. The Company may also be subject to various additional political, economic, and other uncertainties.</p>
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	547362	shares
CY2024Q3	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	100000	usd
CY2024Q3	ltbr	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	200000	usd
CY2023Q4	ltbr	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	0	usd
	ltbr	Lease Payment Under Non Cancellable Operating Leases LeasePaymentUnderNonCancellableOperatingLeases	100000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15276331	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	547362	shares
CY2024Q3	ltbr	Common Stock And All Common Stock Equivalents CommonStockAndAllCommonStockEquivalents	15823693	shares
CY2019Q2	us-gaap	Intercompany Agreements Description IntercompanyAgreementsDescription	Under this amended agreement, the Company pays Stifel a commission equal to 3.0% of the aggregate gross proceeds of any sales of common stock under the agreement. The offering of common stock pursuant to this agreement can be terminated with 10 days written notice by either party
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	0	usd
	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	0	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd

Files In Submission

Name	View Source	Status
0001477932-24-006831-index-headers.html	Edgar Link	pending
0001477932-24-006831-index.html	Edgar Link	pending
0001477932-24-006831.txt	Edgar Link	pending
0001477932-24-006831-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ltbr-20240930.xsd	Edgar Link	pending
ltbr_10q.htm	Edgar Link	pending
ltbr_ex311.htm	Edgar Link	pending
ltbr_ex312.htm	Edgar Link	pending
ltbr_ex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
ltbr-20240930_cal.xml	Edgar Link	unprocessable
ltbr-20240930_def.xml	Edgar Link	unprocessable
ltbr-20240930_lab.xml	Edgar Link	unprocessable
ltbr-20240930_pre.xml	Edgar Link	unprocessable
ltbr_10q_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LTBR
LIGHTBRIDGE Corp Stock $ltbr

2024 Q4 Form 10-Q Financial Statement

#000147793224006831 Filed on November 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTBR LIGHTBRIDGE Corp Stock $ltbr

2024 Q4 Form 10-Q Financial Statement

#000147793224006831 Filed on November 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTBR
LIGHTBRIDGE Corp Stock $ltbr